Emerging biomarkers such as GALAD (Gender, Age, Lens culinaris agglutinin-reactive AFP (AFP-L3), AFP, and Des-gamma-carboxyprothrombin) and circulating tumor DNA (ctDNA) are currently being extensively explored [4,5]. This evidence concerns the gene AFP and neoplasm.